Improving the lives of cancer patients with existing non-cancer generic drugs
Reboot Rx is the nonprofit health tech startup dedicated to fast-tracking the development of affordable cancer treatments using repurposed generic drugs, AI technology, and innovative funding models.
New publication in the journal Frontiers in Pharmacology
Laura Kleiman's Op-Ed in The Boston Globe
Case study by Amazon Web Services and The Chronicle of Philanthropy
Reboot Rx featured in Inside Philanthropy
Laura Kleiman profiled in Forbes
Blog post on impact investing and funding clinical trials testing new uses for generic drugs
Laura Kleiman named a Henri Termeer Fellow
Reboot: COVID-Cancer Project covered by The ASCO Post
Reboot Rx is solving a big problem. Each year worldwide…
20 MILLION
Cancer diagnoses
10 MILLION
People die from cancer
$1 TRILLION
Spent on cancer care
